Pathogenesis and treatment of cardiomyopathy

G C Fonarow1

  • 1UCLA School of Medicine, Ahmanson-UCLA Cardiomyopathy Center, Los Angeles, Calif., USA.

Advances in Internal Medicine
|January 25, 2002
PubMed

Insights

Dilated cardiomyopathy, a serious heart condition, can lead to heart failure. Advances in understanding its causes and treatments like neurohumoral blockade offer improved outcomes, but new therapies are crucial.

Area of Science:

  • Cardiology
  • Genetics
  • Molecular Biology

Background:

  • Dilated cardiomyopathy (DCM) is a complex heart muscle disease with varied etiologies.
  • Untreated DCM often progresses to end-stage heart failure and carries a risk of sudden cardiac death.
  • Significant progress has been made in elucidating the pathogenic mechanisms underlying DCM.

Purpose of the Study:

  • To review recent advances in understanding DCM pathogenesis.
  • To discuss current therapeutic strategies and their impact on patient outcomes.
  • To highlight the need for novel treatments given limitations of existing options.

Main Methods:

  • Review of current scientific literature on dilated cardiomyopathy.
  • Analysis of mechanisms involved in disease progression.
  • Evaluation of established and emerging treatment modalities.

Main Results:

  • Neurohumoral blockade has improved outcomes by counteracting ventricular remodeling.
  • Cardiac transplantation benefits advanced cases but is limited by donor organ availability.
  • Understanding genetic and cellular defects is key to identifying new therapeutic targets.

Conclusions:

  • While current treatments have improved prognosis, novel therapeutic strategies are essential for dilated cardiomyopathy.
  • Further research into the genetic and cellular basis of DCM will uncover new targets for restoring cardiac function.
  • Addressing the donor heart shortage necessitates the development of alternative and regenerative therapies.

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...